Supernus Pharmaceuticals ...

39.04
-0.11 (-0.28%)
At close: Jan 29, 2025, 3:59 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
Cash & Equivalents 75.05M 93.12M 203.43M 288.64M 181.38M 192.25M 100.30M 90.12M 62.19M 74.34M 82.19M 88.51M 48.54M 23.74M 31.41M 52.88M
Short-Term Investments 179.82M 368.21M 136.25M 133.89M 165.69M 163.77M 39.74M 23.72M 28.04M 37.94M 49.21M 48.21M n/a 8.96M 35.12M 7.50M
Long-Term Investments 16.62M 93.90M 119.17M 350.36M 591.77M 418.80M 133.64M 75.41M 55.01M 19.82M 8.76M n/a n/a n/a n/a n/a
Other Long-Term Assets 8.51M -10.00M -36.12M 8.03M 615.00K 380.00K 389.00K 20.19M 391.00K 6.35M 1.52M 144.00K 2.11M 4.80M 3.79M 4.09M
Receivables 144.16M 165.50M 148.93M 140.88M 87.33M 102.92M 65.59M 41.53M 25.91M 17.27M 5.05M 675.00K n/a 158.00K 3.74M 2.28M
Inventory 77.41M 91.54M 85.96M 48.33M 26.63M 25.66M 16.30M 16.80M 12.59M 13.44M 7.15M 1.15M 389.00K 6.75M 2.35M 6.55M
Other Current Assets 16.68M 15.78M 54.04M 37.36M 23.22M 17.78M 13.04M 5.91M 5.26M 7.52M 2.76M 1.13M 466.00K 6.95M 267.00K 252.51K
Total Current Assets 493.11M 734.15M 601.59M 630.42M 472.64M 493.49M 228.45M 151.40M 105.98M 108.89M 97.16M 91.74M 49.40M 39.81M 72.88M 69.46M
Property-Plant & Equipment 42.52M 15.17M 16.95M 37.82M 38.35M 4.09M 5.12M 4.34M 3.87M 2.45M 2.55M 1.42M 1.31M 1.25M 1.86M 1.99M
Goodwill & Intangibles 716.91M 819.48M 902.21M 442.25M 24.84M 31.37M 36.02M 16.49M 976.00K 5.43M 1.16M 683.00K 912.00K 1.14M 1.37M 1.60M
Total Long-Term Assets 784.56M 968.36M 1.09B 873.68M 687.64M 484.32M 196.01M 158.16M 82.75M 28.62M 13.83M 2.25M 4.33M 7.20M 7.02M 7.68M
Total Assets 1.28B 1.70B 1.69B 1.50B 1.16B 977.81M 424.46M 309.57M 188.73M 137.51M 111.00M 93.99M 53.73M 47.01M 79.90M 77.13M
Account Payables 1.96M 10.54M 9.33M 6.15M 10.14M 3.19M 6.84M 8.05M 4.31M 1.86M 3.14M 2.81M 10.08M 11.26M 6.25M 4.47M
Deferred Revenue n/a 49.81M 126.25M 122.43M 144.38M -2.18M 287.00K 209.00K 176.00K 143.00K 8.09M 508.00K 232.00K n/a n/a n/a
Short-Term Debt 8.33M 408.76M 13.72M 12.84M 6.07M 2.18M 4.28M n/a -17.14M n/a n/a 11.81M 8.18M n/a n/a n/a
Other Current Liabilities 279.90M 268.66M 292.33M 226.12M 141.93M 143.60M 95.65M 72.48M 51.95M 25.49M 15.17M 7.86M 1.69M 3.94M 3.79M 3.81M
Total Current Liabilities 290.20M 687.96M 315.38M 245.11M 160.59M 161.35M 123.00M 80.74M 56.10M 27.49M 26.40M 22.98M 18.77M 15.21M 10.03M 8.27M
Long-Term Debt 33.20M 36.00M 420.55M 423.98M 375.61M 329.46M 22.26M 4.17M 7.08M 26.95M 34.39M 11.09M 21.77M 75.00M 75.00M 75.00M
Other Long-Term Liabilities 7.80M 42.54M 52.02M 90.16M 28.66M 33.97M 10.58M 31.41M 35.21M 10.44M 15.32M 2.04M 1.40M 1.12M 1.02M 169.62K
Total Long-Term Liabilities 65.96M 128.35M 557.92M 514.14M 404.27M 363.44M 33.98M 37.07M 13.76M 38.66M 51.13M 13.44M 25.52M 76.12M 76.02M 75.61M
Total Liabilities 356.16M 816.30M 873.30M 759.24M 564.85M 524.79M 156.98M 117.81M 69.86M 66.15M 77.53M 36.42M 44.29M 91.33M 86.06M 83.88M
Total Debt 41.53M 437.97M 420.55M 390.33M 375.61M 329.46M 26.54M 4.17M 7.19M 26.95M 34.39M 22.90M 29.49M 75.00M 75.00M 75.00M
Common Stock 55.00K 54.00K 53.00K 53.00K 53.00K 52.00K 51.00K 50.00K 49.00K 43.00K 40.00K 31.00K 14.00K 2.00K 6.00K 5.52K
Retained Earnings 482.56M 481.25M 379.92M 326.50M 199.55M 86.49M -26.82M -84.29M -144.64M -158.66M -178.53M -86.25M -39.97M -93.79M -55.32M -55.78M
Comprehensive Income -593.00K -3.21M 1.54M 8.97M 7.42M -3.16M -747.00K -134.00K -488.00K -154.00K n/a -57.00K 1K n/a 2.00K -2.15M
Shareholders Equity 921.52M 886.20M 815.85M 744.86M 595.43M 453.02M 267.48M 191.75M 118.88M 71.35M 33.46M 57.57M 9.44M -44.32M -6.16M -6.75M
Total Investments 196.44M 462.11M 255.41M 484.25M 757.47M 582.57M 173.37M 99.13M 83.05M 57.76M 57.97M 48.21M n/a 8.96M 35.12M 7.50M

Create Price Alert on SUPN

Your price alert will notify you when the stock price is above 39.04.

Add to Watchlist